Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study
Keyword(s):
Keyword(s):
2017 ◽
Vol 12
(1)
◽
pp. S1172-S1173
◽
Keyword(s):
2021 ◽
Keyword(s):
Keyword(s):
2021 ◽
Vol 19
(3.5)
◽
pp. HSR21-047